The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker

Aquaporins (AQPs) are transmembrane channels essential for water, energy, and redox homeostasis, with proven involvement in a variety of pathophysiological conditions such as edema, glaucoma, nephrogenic diabetes insipidus, oxidative stress, sepsis, cancer, and metabolic dysfunctions. The 13 AQPs pr...

Full description

Bibliographic Details
Main Authors: Inês V. da Silva, Sabino Garra, Giuseppe Calamita, Graça Soveral
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/12/7/897
_version_ 1797433831725203456
author Inês V. da Silva
Sabino Garra
Giuseppe Calamita
Graça Soveral
author_facet Inês V. da Silva
Sabino Garra
Giuseppe Calamita
Graça Soveral
author_sort Inês V. da Silva
collection DOAJ
description Aquaporins (AQPs) are transmembrane channels essential for water, energy, and redox homeostasis, with proven involvement in a variety of pathophysiological conditions such as edema, glaucoma, nephrogenic diabetes insipidus, oxidative stress, sepsis, cancer, and metabolic dysfunctions. The 13 AQPs present in humans are widely distributed in all body districts, drawing cell lineage-specific expression patterns closely related to cell native functions. Compelling evidence indicates that AQPs are proteins with great potential as biomarkers and targets for therapeutic intervention. Aquaporin-9 (AQP9) is the most expressed in the liver, with implications in general metabolic and redox balance due to its aquaglyceroporin and peroxiporin activities, facilitating glycerol and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) diffusion across membranes. AQP9 is also expressed in other tissues, and their altered expression is described in several human diseases, such as liver injury, inflammation, cancer, infertility, and immune disorders. The present review compiles the current knowledge of AQP9 implication in diseases and highlights its potential as a new biomarker for diagnosis and prognosis in clinical medicine.
first_indexed 2024-03-09T10:22:25Z
format Article
id doaj.art-9603106da9b34520802987577162c668
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-09T10:22:25Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-9603106da9b34520802987577162c6682023-12-01T21:55:20ZengMDPI AGBiomolecules2218-273X2022-06-0112789710.3390/biom12070897The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical BiomarkerInês V. da Silva0Sabino Garra1Giuseppe Calamita2Graça Soveral3Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, PortugalDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari Aldo Moro, 70125 Bari, ItalyDepartment of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari Aldo Moro, 70125 Bari, ItalyResearch Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisboa, PortugalAquaporins (AQPs) are transmembrane channels essential for water, energy, and redox homeostasis, with proven involvement in a variety of pathophysiological conditions such as edema, glaucoma, nephrogenic diabetes insipidus, oxidative stress, sepsis, cancer, and metabolic dysfunctions. The 13 AQPs present in humans are widely distributed in all body districts, drawing cell lineage-specific expression patterns closely related to cell native functions. Compelling evidence indicates that AQPs are proteins with great potential as biomarkers and targets for therapeutic intervention. Aquaporin-9 (AQP9) is the most expressed in the liver, with implications in general metabolic and redox balance due to its aquaglyceroporin and peroxiporin activities, facilitating glycerol and hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) diffusion across membranes. AQP9 is also expressed in other tissues, and their altered expression is described in several human diseases, such as liver injury, inflammation, cancer, infertility, and immune disorders. The present review compiles the current knowledge of AQP9 implication in diseases and highlights its potential as a new biomarker for diagnosis and prognosis in clinical medicine.https://www.mdpi.com/2218-273X/12/7/897aquaporinsaquaporin-9clinical biomarkersmembrane permeability
spellingShingle Inês V. da Silva
Sabino Garra
Giuseppe Calamita
Graça Soveral
The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker
Biomolecules
aquaporins
aquaporin-9
clinical biomarkers
membrane permeability
title The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker
title_full The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker
title_fullStr The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker
title_full_unstemmed The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker
title_short The Multifaceted Role of Aquaporin-9 in Health and Its Potential as a Clinical Biomarker
title_sort multifaceted role of aquaporin 9 in health and its potential as a clinical biomarker
topic aquaporins
aquaporin-9
clinical biomarkers
membrane permeability
url https://www.mdpi.com/2218-273X/12/7/897
work_keys_str_mv AT inesvdasilva themultifacetedroleofaquaporin9inhealthanditspotentialasaclinicalbiomarker
AT sabinogarra themultifacetedroleofaquaporin9inhealthanditspotentialasaclinicalbiomarker
AT giuseppecalamita themultifacetedroleofaquaporin9inhealthanditspotentialasaclinicalbiomarker
AT gracasoveral themultifacetedroleofaquaporin9inhealthanditspotentialasaclinicalbiomarker
AT inesvdasilva multifacetedroleofaquaporin9inhealthanditspotentialasaclinicalbiomarker
AT sabinogarra multifacetedroleofaquaporin9inhealthanditspotentialasaclinicalbiomarker
AT giuseppecalamita multifacetedroleofaquaporin9inhealthanditspotentialasaclinicalbiomarker
AT gracasoveral multifacetedroleofaquaporin9inhealthanditspotentialasaclinicalbiomarker